Zhou, R., Song, L., Zhang, W., Shao, L., Li, X., & Li, X. (2021). Combination of Osimertinib and Anlotinib May Overcome the Resistance Mediated by in cis EGFR T790M-C797S in NSCLC: A Case Report. Onco Targets Ther.
Citação norma ChicagoZhou, Rengui, Lei Song, Wenwen Zhang, Lin Shao, Xi Li, and Xiangyong Li. "Combination of Osimertinib and Anlotinib May Overcome the Resistance Mediated By in Cis EGFR T790M-C797S in NSCLC: A Case Report." Onco Targets Ther 2021.
Citação norma MLAZhou, Rengui, et al. "Combination of Osimertinib and Anlotinib May Overcome the Resistance Mediated By in Cis EGFR T790M-C797S in NSCLC: A Case Report." Onco Targets Ther 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.